Page last updated: 2024-10-27

berotek and Atherogenesis

berotek has been researched along with Atherogenesis in 1 studies

Fenoterol: A synthetic adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.
fenoterol : A member of the class resorcinols that is 5-(1-hydroxyethyl)benzene-1,3-diol in which one of the methyl hydrogens is replaced by a 1-(4-hydroxyphenyl)propan-2-amino group. A beta2-adrenergic agonist, it is used (as the hydrobromide salt) as a bronchodilator in the management of reversible airway obstruction.

Research Excerpts

ExcerptRelevanceReference
"Hypercholesterolemia is an atherosclerotic condition that is associated with impaired neovascularization in response to ischemia."1.46MicroRNA-150 Modulates Ischemia-Induced Neovascularization in Atherosclerotic Conditions. ( Desjarlais, M; Dhahri, W; Dussault, S; Mathieu, R; Rivard, A, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Desjarlais, M1
Dussault, S1
Dhahri, W1
Mathieu, R1
Rivard, A1

Other Studies

1 other study available for berotek and Atherogenesis

ArticleYear
MicroRNA-150 Modulates Ischemia-Induced Neovascularization in Atherosclerotic Conditions.
    Arteriosclerosis, thrombosis, and vascular biology, 2017, Volume: 37, Issue:5

    Topics: Adaptor Proteins, Vesicular Transport; Animals; Apolipoproteins E; Atherosclerosis; Cells, Cultured;

2017